AOP-Wiki

API

All KERs

Showing 876 to 900 of 3002 KERs

ID	Upstream Event	Downstream Event	Creation Date	Last Updated	AOPs

2477	1881: Decreased, atRA concentration	1882: Disrupted, meiotic initiation in oocyte	Sep 10, 2021	Jul 4, 2025	1 AOP 398: Decreased ALDH1A (RALDH) activity leading to decreased fertility via disrupted meiotic initiation of fetal oogonia
2561	1881: Decreased, atRA concentration	1682: Disruption, Progenitor cells of second heart field	Feb 8, 2022	Feb 15, 2022	1 AOP 436: Inhibition of RALDH2 causes reduced all-trans retinoic acid levels, leading to transposition of the great arteries
2630	1987: Decreased , Androgen and Progestin	1988: Decreased, Maturation Inducing Steroids Surge by Granulosa cells	Apr 5, 2022	Apr 5, 2022	1 AOP 445: Estrogen Receptor Alpha Agonism leads to Impaired Reproduction
1542	1409: Decreased, angiogenesis	1385: Activated, gastric ulcer formation	Jun 2, 2017	Jun 2, 2017	1 AOP 228: NSAID induced PTGS2 inactivation to gastric ulcer
645	627: Decreased, anxiety	629: Decreased, sheltering	Nov 29, 2016	Dec 3, 2016	1 AOP 98: 5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to decreased shelter seeking and increased predation
1248	1183: Decreased, Apoptosis (Epithelial Cells)	1192: Increased, Ductal Hyperplasia	Nov 29, 2016	Dec 3, 2016	1 AOP 200: Estrogen receptor activation leading to breast cancer
2914	1183: Decreased, Apoptosis (Epithelial Cells)	854: Alterations, Cellular proliferation / hyperplasia	May 11, 2023	May 11, 2023	1 AOP 495: Androgen receptor activation leading to prostate cancer
801	800: Decreased, Aromatase (Cyp19a1) mRNA	3: Reduction, 17beta-estradiol synthesis by ovarian granulosa cells	Nov 29, 2016	Dec 3, 2016	2 AOPs 122: Prolyl hydroxylase inhibition leading to reproductive dysfunction via increased HIF1 heterodimer formation 123: Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription
2870	2123: decreased, Bcl-2	55: Cell injury/death	Apr 4, 2023	Apr 4, 2023	1 AOP 490: Co-activation of IP3R and RyR leads to reduced IQ through non-cholinergic mechanisms
2873	2123: decreased, Bcl-2	1825: Increase, Cell death	Apr 4, 2023	Apr 4, 2023	None
1540	1407: Decreased, bicarbonate	1405: Reduced, mucosal defense	Jun 2, 2017	Jun 2, 2017	1 AOP 227: NSAID induced PTGS1 inactivation to gastric ulcer
1101	1058: Decreased, bile flow	1059: Increased, cholestasis	Nov 29, 2016	Dec 3, 2016	1 AOP 166: PPARalpha activation leading to pancreatic acinar tumors in the rat and mouse
3347	2261: Decreased, blood plasma volume	2238: Increased, Blood viscosity	Sep 20, 2024	Dec 3, 2024	1 AOP 539: Decreased Sodium/Potassium ATPase activity leads to Heart failure
62	52: Decreased, Calcium influx	341: Impairment, Learning and memory	Nov 29, 2016	Dec 3, 2016	None
347	52: Decreased, Calcium influx	381: BDNF, Reduced	Nov 29, 2016	Jun 13, 2018	2 AOPs 12: Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development leads to neurodegeneration with impairment in learning and memory in aging 13: Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities
3167	656: Decreased COUP-TFII in Leydig cells	647: Decreased, steroidogenic protein expression	Mar 20, 2024	Dec 3, 2024	2 AOPs 526: Decreased, Chicken Ovalbumin Upstream Promoter Transcription Factor II (COUP-TFII) leads to Impaired, Spermatogenesis 527: Decreased, Chicken Ovalbumin Upstream Promoter Transcription Factor II (COUP-TFII) leads to Hypospadias, increased
2072	807: Decreased, cholesterol	1756: Decreased, 11KT	Mar 23, 2020	May 6, 2020	1 AOP 323: PPARalpha Agonism Leading to Decreased Viable Offspring via Decreased 11-Ketotestosterone
3201	807: Decreased, cholesterol	1690: Decrease, circulating testosterone levels	Apr 25, 2024	Apr 25, 2024	1 AOP 124: HMG-CoA reductase inhibition leading to decreased fertility
3519	2321: Decreased, CYP11A1 activity	2319: Decreased, Pregnenolone levels	Apr 8, 2025	Apr 8, 2025	None
537	482: Decreased, DHB4/HSD17B4	451: Inhibition, Mitochondrial fatty acid beta-oxidation	Nov 29, 2016	Dec 3, 2016	1 AOP 61: NFE2L2/FXR activation leading to hepatic steatosis
1121	1083: Decreased, Dopaminergic activity	1084: Increased, prolactin secretion	Nov 29, 2016	Dec 3, 2016	1 AOP 170: Anti-dopaminergic activity leading to mammary adenomas and carcinomas in the SD rat
3254	2233: Decreased, ERαβ heterodimers	1262: Apoptosis	Jun 19, 2024	Jun 19, 2024	1 AOP 535: Binding and activation of GPER leading to learning and memory impairments
1435	1347: Decreased, extracellular serotonin	1326: Increased, 5-HT3	Apr 14, 2017	Apr 14, 2017	1 AOP 214: Network of SSRIs (selective serotonin reuptake inhibitors)
1436	1347: Decreased, extracellular serotonin	1328: Inactivated, 5-HTR	Apr 14, 2017	Apr 14, 2017	5 AOPs 214: Network of SSRIs (selective serotonin reuptake inhibitors) 221: Mental stress to depression 222: Mental stress to agitation 225: Serotonin transporter activation to agitation 224: Serotonin transporter activation to depression
1437	1347: Decreased, extracellular serotonin	1336: Activation, 5-HT2A	Apr 14, 2017	Apr 14, 2017	1 AOP 214: Network of SSRIs (selective serotonin reuptake inhibitors)

Key Event Relationships (KERs)

All KERs